Nyxoah’s Genio Therapy Wins the 2026 Prix Galien UK for Best Medical Technology

▤ Summary

Nyxoah’s Genio therapy won the 2026 Prix Galien UK award for Best Medical Technology. The recognition highlights the company’s hypoglossal nerve stimulation treatment for obstructive sleep apnea and its clinical impact on patients. Nyxoah says the award reflects work across engineering, clinical adoption, and patient support, especially in the UK. The company also points to continued momentum after FDA approval, U.S. commercial launch, and a recent financing round that supports expansion.

▦ Linked Companies